FDA Approved: NEXLETOL — Original Application (Esperion Therapeutics, Inc.)

View source ↗

Summary

FDA approved Nexletol (bempedoic acid) as an original application for adults with heterozygous familial hypercholesterolemia or established atherosclerotic card…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Heterozygous Familial Hypercholesterolemia
• Hypercholesterolemia

Drugs mentioned

• Nexletol (bempedoic acid)

Snippet

ORIG AP for NEXLETOL (BEMPEDOIC ACID)